These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 21507640)

  • 1. The identification of 4,7-disubstituted naphthoic acid derivatives as UDP-competitive antagonists of P2Y14.
    Gauthier JY; Belley M; Deschênes D; Fournier JF; Gagné S; Gareau Y; Hamel M; Hénault M; Hyjazie H; Kargman S; Lavallée G; Levesque JF; Li L; Mamane Y; Mancini J; Morin N; Mulrooney E; Robichaud J; Thérien M; Tranmer G; Wang Z; Wu J; Black WC
    Bioorg Med Chem Lett; 2011 May; 21(10):2836-9. PubMed ID: 21507640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and SAR of pyrimidine-based, non-nucleotide P2Y14 receptor antagonists.
    Guay D; Beaulieu C; Belley M; Crane SN; DeLuca J; Gareau Y; Hamel M; Henault M; Hyjazie H; Kargman S; Chan CC; Xu L; Gordon R; Li L; Mamane Y; Morin N; Mancini J; Thérien M; Tranmer G; Truong VL; Wang Z; Black WC
    Bioorg Med Chem Lett; 2011 May; 21(10):2832-5. PubMed ID: 21507642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimization of the physicochemical and pharmacokinetic attributes in a 6-azauracil series of P2X7 receptor antagonists leading to the discovery of the clinical candidate CE-224,535.
    Duplantier AJ; Dombroski MA; Subramanyam C; Beaulieu AM; Chang SP; Gabel CA; Jordan C; Kalgutkar AS; Kraus KG; Labasi JM; Mussari C; Perregaux DG; Shepard R; Taylor TJ; Trevena KA; Whitney-Pickett C; Yoon K
    Bioorg Med Chem Lett; 2011 Jun; 21(12):3708-11. PubMed ID: 21565499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of novel P2Y14 agonist and antagonist using conventional and nonconventional methods.
    Hamel M; Henault M; Hyjazie H; Morin N; Bayly C; Skorey K; Therien AG; Mancini J; Brideau C; Kargman S
    J Biomol Screen; 2011 Oct; 16(9):1098-105. PubMed ID: 21821827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Applying the pro-drug approach to afford highly bioavailable antagonists of P2Y(14).
    Robichaud J; Fournier JF; Gagné S; Gauthier JY; Hamel M; Han Y; Hénault M; Kargman S; Levesque JF; Mamane Y; Mancini J; Morin N; Mulrooney E; Wu J; Black WC
    Bioorg Med Chem Lett; 2011 Jul; 21(14):4366-8. PubMed ID: 21689930
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A selective high-affinity antagonist of the P2Y14 receptor inhibits UDP-glucose-stimulated chemotaxis of human neutrophils.
    Barrett MO; Sesma JI; Ball CB; Jayasekara PS; Jacobson KA; Lazarowski ER; Harden TK
    Mol Pharmacol; 2013 Jul; 84(1):41-9. PubMed ID: 23592514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploring a 2-naphthoic acid template for the structure-based design of P2Y14 receptor antagonist molecular probes.
    Kiselev E; Barrett MO; Katritch V; Paoletta S; Weitzer CD; Brown KA; Hammes E; Yin AL; Zhao Q; Stevens RC; Harden TK; Jacobson KA
    ACS Chem Biol; 2014 Dec; 9(12):2833-42. PubMed ID: 25299434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. UDP is a competitive antagonist at the human P2Y14 receptor.
    Fricks IP; Maddileti S; Carter RL; Lazarowski ER; Nicholas RA; Jacobson KA; Harden TK
    J Pharmacol Exp Ther; 2008 May; 325(2):588-94. PubMed ID: 18252808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and SAR development of novel P2X7 receptor antagonists for the treatment of pain: part 1.
    Matasi JJ; Brumfield S; Tulshian D; Czarnecki M; Greenlee W; Garlisi CG; Qiu H; Devito K; Chen SC; Sun Y; Bertorelli R; Geiss W; Le VD; Martin GS; Vellekoop SA; Haber J; Allard ML
    Bioorg Med Chem Lett; 2011 Jun; 21(12):3805-8. PubMed ID: 21570840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conformationally constrained farnesoid X receptor (FXR) agonists: Naphthoic acid-based analogs of GW 4064.
    Akwabi-Ameyaw A; Bass JY; Caldwell RD; Caravella JA; Chen L; Creech KL; Deaton DN; Jones SA; Kaldor I; Liu Y; Madauss KP; Marr HB; McFadyen RB; Miller AB; Navas F; Parks DJ; Spearing PK; Todd D; Williams SP; Wisely GB
    Bioorg Med Chem Lett; 2008 Aug; 18(15):4339-43. PubMed ID: 18621523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 2-Nitrophenylcarbamoyl-(S)-prolyl-(S)-3-(2-naphthyl)alanyl-N-benzyl-N - methylamide (SDZ NKT 343), a potent human NK1 tachykinin receptor antagonist with good oral analgesic activity in chronic pain models.
    Walpole C; Ko SY; Brown M; Beattie D; Campbell E; Dickenson F; Ewan S; Hughes GA; Lemaire M; Lerpiniere J; Patel S; Urban L
    J Med Chem; 1998 Aug; 41(17):3159-73. PubMed ID: 9703462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure-Based Design of 3-(4-Aryl-1H-1,2,3-triazol-1-yl)-Biphenyl Derivatives as P2Y14 Receptor Antagonists.
    Junker A; Balasubramanian R; Ciancetta A; Uliassi E; Kiselev E; Martiriggiano C; Trujillo K; Mtchedlidze G; Birdwell L; Brown KA; Harden TK; Jacobson KA
    J Med Chem; 2016 Jul; 59(13):6149-68. PubMed ID: 27331270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery and structure-activity relationships of a series of pyroglutamic acid amide antagonists of the P2X7 receptor.
    Abdi MH; Beswick PJ; Billinton A; Chambers LJ; Charlton A; Collins SD; Collis KL; Dean DK; Fonfria E; Gleave RJ; Lejeune CL; Livermore DG; Medhurst SJ; Michel AD; Moses AP; Page L; Patel S; Roman SA; Senger S; Slingsby B; Steadman JG; Stevens AJ; Walter DS
    Bioorg Med Chem Lett; 2010 Sep; 20(17):5080-4. PubMed ID: 20673717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and evaluation of naphthoic acid derivatives as fluorescent probes to screen advanced glycation end-products breakers.
    Séro L; Calard F; Sanguinet L; Levillain E; Richomme P; Séraphin D; Derbré S
    Bioorg Med Chem Lett; 2012 Nov; 22(21):6716-20. PubMed ID: 23010265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design, synthesis and anti-inflammatory evaluation of 3-amide benzoic acid derivatives as novel P2Y
    Zhang Z; Hao K; Li H; Lu R; Liu C; Zhou M; Li B; Meng Z; Hu Q; Jiang C
    Eur J Med Chem; 2019 Nov; 181():111564. PubMed ID: 31376563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery and computational studies of 2-phenyl-benzoxazole acetamide derivatives as promising P2Y
    Zhou M; Wang W; Wang Z; Wang Y; Zhu Y; Lin Z; Tian S; Huang Y; Hu Q; Li H
    Eur J Med Chem; 2022 Jan; 227():113933. PubMed ID: 34689072
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery of N-Substituted Acetamide Derivatives as Promising P2Y
    Liu W; Mao S; Wang Y; Wang M; Li M; Sun M; Yao Y; Song C; Duan Y
    J Med Chem; 2024 Jun; 67(12):10233-10247. PubMed ID: 38874515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. P2Y14R for inflammation therapy: is it a promising target?
    Wang Y; Duan Y
    Future Med Chem; 2021 Sep; 13(18):1493-1495. PubMed ID: 34278830
    [No Abstract]   [Full Text] [Related]  

  • 19. Small molecule antagonists of the CC chemokine receptor 4 (CCR4).
    Burdi DF; Chi S; Mattia K; Harrington C; Shi Z; Chen S; Jacutin-Porte S; Bennett R; Carson K; Yin W; Kansra V; Gonzalo JA; Coyle A; Jaffee B; Ocain T; Hodge M; LaRosa G; Harriman G
    Bioorg Med Chem Lett; 2007 Jun; 17(11):3141-5. PubMed ID: 17395464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of a Series of 4-Amide-thiophene-2-carboxyl Derivatives as Highly Potent P2Y
    Wang YH; Liu CX; Zhang YH; Yang YL; Zhao Y; Han L; Wang QQ; Xiao W; Hu QH; Ding ZH; Zhou MZ; Jiang C
    J Med Chem; 2024 Jul; 67(14):11989-12011. PubMed ID: 38959216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.